New nerve block could cut opioid use after heart surgery

NCT ID NCT07666178

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a continuous nerve block (erector spinae plane block) can reduce pain and morphine use after coronary artery bypass surgery. 78 adults with good heart function will receive either the nerve block with ropivacaine or standard painkillers. The goal is to see if this newer technique improves recovery and lowers chronic pain risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ropivacaine
What this could lead to
If it works, this could provide better pain control after heart surgery with less need for strong opioids.
What could go wrong
This is a small, early-phase trial focused on pain relief, not a cure. The nerve block may not work better than standard care, and there are risks like infection or allergic reaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ERECTOR SPINAE PLANE BLOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Bites and Stings

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • InCor

    RECRUITING

    São Paulo, São Paulo, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.